A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts

Orthofix Medical (NASDAQ:OFIX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	2	2	1	0	0
Last 30D	1	0	0	0	0
1M Ago	1	2	0	0	0
2M Ago	0	0	1	0	0
3M Ago	0	0	0	0	0

In the assessment of 12-month price targets, analysts unveil insights for Orthofix Medical, presenting an average target of $17.4, a high estimate of $20.00, and a low estimate of $14.00. This current average has decreased by 15.12% from the previous average price target of $20.50.

Investigating Analyst Ratings: An Elaborate Study

A clear picture of Orthofix Medical's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Thomas Stephan	Stifel	Lowers	Buy	$18.00	$22.00
Caitlin Burrows	Canaccord Genuity	Lowers	Buy	$20.00	$24.00
Michael Petusky	Barrington Research	Lowers	Outperform	$17.00	$18.00
Michael Petusky	Barrington Research	Maintains	Outperform	$18.00	$18.00
Mathew Blackman	TD Cowen	Announces	Hold	$14.00	-

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Orthofix Medical. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Orthofix Medical compared to the broader market.
• Price Targets: Gaining insights, analysts provide estimates for the future value of Orthofix Medical's stock. This comparison reveals trends in analysts' expectations over time.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Orthofix Medical's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Orthofix Medical analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

A Deep Dive into Orthofix Medical's Financials

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Orthofix Medical's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 4.59%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Orthofix Medical's net margin is impressive, surpassing industry averages. With a net margin of -11.09%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Orthofix Medical's ROE stands out, surpassing industry averages. With an impressive ROE of -5.06%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Orthofix Medical's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -2.73%, the company showcases efficient use of assets and strong financial health.

Debt Management: Orthofix Medical's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.46.

What Are Analyst Ratings?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.